Orhan Sezer
Overview
Explore the profile of Orhan Sezer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
109
Citations
6264
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rosinol L, Beksac M, Zamagni E, van de Donk N, Anderson K, Badros A, et al.
Br J Haematol
. 2021 Mar;
194(3):496-507.
PMID: 33724461
In this review, two types of soft-tissue involvement in multiple myeloma are defined: (i) extramedullary (EMD) with haematogenous spread involving only soft tissues and (ii) paraskeletal (PS) with tumour masses...
2.
Moreau P, Kumar S, San Miguel J, Davies F, Zamagni E, Bahlis N, et al.
Lancet Oncol
. 2021 Mar;
22(3):e105-e118.
PMID: 33662288
This Policy Review presents the International Myeloma Working Group's clinical practice recommendations for the treatment of relapsed and refractory multiple myeloma. Based on the results of phase 2 and phase...
3.
Knop S, Engelhardt M, Liebisch P, Meisner C, Holler E, Metzner B, et al.
Leukemia
. 2019 Aug;
33(11):2710-2719.
PMID: 31462732
This phase 3 trial compared tandem autologous stem cell transplantation (autoSCT) versus autoSCT followed by reduced-intensity conditioning allogeneic stem cell transplantation (auto/alloSCT) in patients with newly diagnosed multiple myeloma (MM)...
4.
Sezer O, Beksac M, Hajek R, Sucak G, Cagirgan S, Linkesch W, et al.
Br J Haematol
. 2017 Apr;
178(1):61-71.
PMID: 28382618
This phase II study explored the effects of bortezomib consolidation versus observation on myeloma-related bone disease in patients who had a partial response or better after frontline high-dose therapy and...
5.
Straka C, Liebisch P, Salwender H, Hennemann B, Metzner B, Knop S, et al.
Haematologica
. 2016 Sep;
101(11):1398-1406.
PMID: 27662018
Autologous transplantation is controversial for older patients with multiple myeloma. The role of age-adjusted high-dose melphalan and the impact of induction chemotherapy cycles is still unclear. A total of 434...
6.
Terpos E, Kleber M, Engelhardt M, Zweegman S, Gay F, Kastritis E, et al.
Haematologica
. 2015 Oct;
100(10):1254-66.
PMID: 26432383
The European Myeloma Network provides recommendations for the management of the most common complications of multiple myeloma. Whole body low-dose computed tomography is more sensitive than conventional radiography in depicting...
7.
Giralt S, Garderet L, Durie B, Cook G, Gahrton G, Bruno B, et al.
Biol Blood Marrow Transplant
. 2015 Oct;
21(12):2039-2051.
PMID: 26428082
In contrast to the upfront setting in which the role of high-dose therapy with autologous hematopoietic cell transplantation (HCT) as consolidation of a first remission in patients with multiple myeloma...
8.
Dimopoulos M, Hillengass J, Usmani S, Zamagni E, Lentzsch S, Davies F, et al.
J Clin Oncol
. 2015 Jan;
33(6):657-64.
PMID: 25605835
Purpose: The aim of International Myeloma Working Group was to develop practical recommendations for the use of magnetic resonance imaging (MRI) in multiple myeloma (MM). Methods: An interdisciplinary panel of...
9.
Rajkumar S, Dimopoulos M, Palumbo A, Blade J, Merlini G, Mateos M, et al.
Lancet Oncol
. 2014 Dec;
15(12):e538-48.
PMID: 25439696
This International Myeloma Working Group consensus updates the disease definition of multiple myeloma to include validated biomarkers in addition to existing requirements of attributable CRAB features (hypercalcaemia, renal failure, anaemia,...
10.
Straka C, Salwender H, Schnabel B, Sandherr M, Wandt H, Hubel K, et al.
Leuk Lymphoma
. 2014 May;
56(2):368-76.
PMID: 24794810
The patient granulocyte-colony stimulating factor (G-CSF) response is represented by the leukocyte peak in the blood induced by a single dose of G-CSF after chemotherapy, and is correlated with subsequent...